循环lncRNA NEAT1与脓毒症患者风险增加、严重程度升高及预后不良相关
本研究纳入152例脓毒症患者和150例健康对照,检测血浆lncRNA NEAT1表达及血清炎性细胞因子水平。结果显示脓毒症患者lncRNA NEAT1表达显著高于健康对照(P < 0.001),ROC曲线下面积AUC为0.730(95% CI: 0.740-0.861),多因素logistic回归显示其与脓毒症风险独立相关(P < 0.001)。在脓毒症患者中,lncRNA NEAT1与APACHE II评分及TNF-α、IL-1β、IL-6、IL-8正相关,与IL-10负相关;非存活者lncRNA NEAT1高于存活者(P = 0.006),预测非存活风险的AUC为0.641(95% CI: 0.536-0.746)。
要点
- 脓毒症患者血浆lncRNA NEAT1表达显著高于健康对照(P < 0.001),预测脓毒症风险的AUC为0.730(95% CI: 0.740-0.861)。
- 多因素logistic回归显示lncRNA NEAT1表达与脓毒症风险独立相关(P < 0.001)。
- 脓毒症患者中lncRNA NEAT1与APACHE II评分正相关(P < 0.001),与TNF-α(P < 0.001)、IL-1β(P = 0.043)、IL-6(P = 0.001)、IL-8(P = 0.038)正相关,与IL-10负相关(P < 0.001)。
- 非存活者lncRNA NEAT1表达高于存活者(P = 0.006),预测非存活风险的AUC为0.641(95% CI: 0.536-0.746)。
适用人群与场景
- 脓毒症患者152例及健康对照150例;血浆和血清样本取自脓毒症患者和健康对照。
研究设计与关键结果
- 研究类型为病例对照研究,纳入152例脓毒症患者和150例健康对照,检测血浆lncRNA NEAT1表达(定量聚合酶链反应)及血清炎性细胞因子(酶联免疫吸附试验)。
- 脓毒症患者血浆lncRNA NEAT1表达显著高于健康对照(P < 0.001);ROC曲线显示lncRNA NEAT1对脓毒症风险有良好预测价值,AUC为0.730(95% CI: 0.740-0.861)。
- 多因素logistic回归分析显示lncRNA NEAT1表达与较高的脓毒症风险独立相关(P < 0.001)。
- 在脓毒症患者中,lncRNA NEAT1表达与APACHE II评分(P < 0.001)、血清TNF-α(P < 0.001)、IL-1β(P = 0.043)、IL-6(P = 0.001)和IL-8(P = 0.038)正相关,与IL-10负相关(P < 0.001)。
- 非存活者lncRNA NEAT1表达高于存活者(P = 0.006);ROC曲线显示lncRNA NEAT1对非存活风险有良好预测价值,AUC为0.641(95% CI: 0.536-0.746)。
证据类型、等级与局限
- 证据类型:病例对照研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为循环lncRNA NEAT1与脓毒症风险增加、严重程度升高、预后不良及促炎细胞因子表达升高相关。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the correlation of circulating long non-coding RNA nuclear-enriched abundant transcript 1 (lncRNA NEAT1) expression with disease risk, severity, prognosis and inflammatory cytokine levels in sepsis patients.
METHODS: 152 sepsis patients and 150 health controls (HCs) were enrolled in this study. Plasma and serum samples were obtained from sepsis patients and HCs, and lncRNA NEAT1 expression in plasma was determined by quantitative polymerase chain reaction, while levels of inflammatory cytokines in serum were detected by enzyme linked immune sorbent assay.
RESULTS: LncRNA NEAT1 expression was remarkably higher in sepsis patients than in HCs (P < 0.001). Receiver operating characteristic (ROC) curve disclosed a good predictive value of lncRNA NEAT1 expression for sepsis risk with area under curve (AUC) of 0.730 (95% CI: 0.740-0.861). Subsequent multivariate logistic regression analysis demonstrated that lncRNA NEAT1 expression was independently associated with higher sepsis risk (P < 0.001). In sepsis patients, lncRNA NEAT1 expression was also observed to be positively correlated with Acute Physiology and Chronic Health Evaluation (APACHE) II score (P < 0.001), serum tumor necrosis factor-α (P < 0.001), interleukin (IL)-1β (P = 0.043), IL-6 (P = 0.001) and IL-8 (P = 0.038), while negatively correlated with IL-10 (P < 0.001). In addition, lncRNA NEAT1 expression was increased in non-survivors compared to survivors (P = 0.006), and ROC curve revealed a good prognostic value of lncRNA NEAT1 for non-survivor risk with AUC 0.641 (95% CI: 0.536-0.746).
CONCLUSION: Circulating lncRNA NEAT1 correlates with increased disease risk, elevated severity and unfavorable prognosis as well as higher expression of pro-inflammatory cytokines in sepsis patients.
参考来源
- Huang Q, Huang C, Luo Y, et al. Circulating lncRNA NEAT1 correlates with increased risk, elevated severity and unfavorable prognosis in sepsis patients. Am J Emerg Med. 2018. PMID: 29936011. doi:10.1016/j.ajem.2018.06.008
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。